#ACTRIMS2021 - Leptin Promotes Inflammation, May Link Obesity to MS multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
Welcome to Noozhawk Asks, a new feature in which you ask the questions, you help decide what Noozhawk investigates, and you work with us to find the answers.
Here’s how it works: You share your questions with us in the nearby box. In some cases, we may work with you to find the answers. In others, we may ask you to vote on your top choices to help us narrow the scope. And we’ll be regularly asking you for your feedback on a specific issue or topic.
We also expect to work together with the reader who asked the winning questions to find the answer together. Noozhawk’s objective is to come at questions from a place of curiosity and openness, and we believe a transparent collaboration is the key to achieve it.
TILT Hires Two Compliance Experts
TILT Holdings Inc. (CSE:TILT) (OTCQX:TLLTF) strengthened its leadership team by welcoming Nicole Moyers as vice president of compliance and Patrick Beyea as director of compliance.
Moyers has extensive experience in government affairs, public service programs, and healthcare.
Previously she served as the Director of Project Development for both Keystone Center of Integrative Wellness and Parea Biosciences and on the Pennsylvania Cannabis Coalition’s Legislative Committee.
Beyea brings practical knowledge in compliance, having served as the Director of Safety and Security at the Eternal Word Television Network and the Director of Investigations at the Massachusetts Cannabis Control Commission.
New study to examine the effects of MS disease-modifying therapy on cognitive fatigue
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, A Biomarker for Cognitive Fatigue in MS using Functional Imaging . The study team includes Glenn Wylie, DPhil, director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research, and Helen Genova, PhD, assistant director of the Center for Neuropsychology and Neuroscience Research.
E-Mail
IMAGE: Dr. DeLuca is senior vice president of Research and Training at Kessler Foundation and professor of neurology and physical medicine and rehabilitation at Rutgers New Jersey Medical School. He. view more
Credit: Kessler Foundation
East Hanover, NJ. February 8, 2021 - Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, A Biomarker for Cognitive Fatigue in MS using Functional Imaging . The study team includes Glenn Wylie, DPhil, director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research, and Helen Genova, PhD, assistant d